Abeona Therapeutics (ABEO) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Abeona Therapeutics (ABEO) over the last 14 years, with Q3 2025 value amounting to $600000.0.
- Abeona Therapeutics' Accumulated Depreciation & Amortization rose 2000.0% to $600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $600000.0, marking a year-over-year increase of 2000.0%. This contributed to the annual value of $2.0 million for FY2024, which is 1304.35% down from last year.
- As of Q3 2025, Abeona Therapeutics' Accumulated Depreciation & Amortization stood at $600000.0, which was up 2000.0% from $600000.0 recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $3.3 million in Q4 2021 and a low of $500000.0 during Q3 2023
- In the last 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization had a median value of $800000.0 in 2021 and averaged $1.1 million.
- In the last 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization tumbled by 3750.0% in 2023 and then surged by 2000.0% in 2025.
- Quarter analysis of 5 years shows Abeona Therapeutics' Accumulated Depreciation & Amortization stood at $3.3 million in 2021, then fell by 6.06% to $3.1 million in 2022, then fell by 25.81% to $2.3 million in 2023, then fell by 13.04% to $2.0 million in 2024, then crashed by 70.0% to $600000.0 in 2025.
- Its last three reported values are $600000.0 in Q3 2025, $600000.0 for Q2 2025, and $500000.0 during Q1 2025.